Peng Qin - Net Worth and Insider Trading
Peng Qin Net Worth
The estimated net worth of Peng Qin is at least $348,936 dollars as of 2024-12-13. Peng Qin is the senior management of Kangmei Pharmaceutical Co Ltd and owns about 130,200 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) stock worth over $348,936. Details can be seen in Peng Qin's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Peng Qin has not made any transactions after 2015-07-21 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Peng Qin
Peng Qin Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Peng Qin owns 1 companies in total, including Kangmei Pharmaceutical Co Ltd (SHSE:600518) .
Click here to see the complete history of Peng Qin’s form 4 insider trades.
Insider Ownership Summary of Peng Qin
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
SHSE:600518 | Kangmei Pharmaceutical Co Ltd | 2015-07-21 | senior management |
Peng Qin Latest Holdings Summary
Peng Qin currently owns a total of 1 stock. Peng Qin owns 130,200 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) as of July 21, 2015, with a value of $348,936.
Latest Holdings of Peng Qin
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
SHSE:600518 | Kangmei Pharmaceutical Co Ltd | 2015-07-21 | 130,200 | 2.68 | 348,936 |
Holding Weightings of Peng Qin
Peng Qin Form 4 Trading Tracker
According to the SEC Form 4 filings, Peng Qin has made a total of 0 transactions in Kangmei Pharmaceutical Co Ltd (SHSE:600518) over the past 5 years. The most-recent trade in Kangmei Pharmaceutical Co Ltd is the acquisition of 30,000 shares on July 21, 2015, which cost Peng Qin around $570,600.
Insider Trading History of Peng Qin
- 1
Peng Qin Trading Performance
GuruFocus tracks the stock performance after each of Peng Qin's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Peng Qin is 7.67%. GuruFocus also compares Peng Qin's trading performance to market benchmark return within the same time period. The performance of stocks bought by Peng Qin within 3 months outperforms 4 times out of 6 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Peng Qin's insider trading performs compared to the benchmark.
Peng Qin Ownership Network
Peng Qin Owned Company Details
What does Kangmei Pharmaceutical Co Ltd do?
Who are the key executives at Kangmei Pharmaceutical Co Ltd?
Peng Qin is the senior management of Kangmei Pharmaceutical Co Ltd. Other key executives at Kangmei Pharmaceutical Co Ltd include senior management Li Jian Hua , senior management Wang Min , and senior management Lin Guo Xiong .
Kangmei Pharmaceutical Co Ltd (SHSE:600518) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Kangmei Pharmaceutical Co Ltd (SHSE:600518) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Kangmei Pharmaceutical Co Ltd (SHSE:600518)'s detailed insider trading history can be found in Insider Trading Tracker table.
Kangmei Pharmaceutical Co Ltd Insider Transactions
Peng Qin Mailing Address
Above is the net worth, insider trading, and ownership report for Peng Qin. Currently GuruFocus does not have mailing address information for Peng Qin.